Last reviewed · How we verify
P144 cream
At a glance
| Generic name | P144 cream |
|---|---|
| Sponsor | ISDIN |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Open Label Extension (OLE) for the Patients Treated in the ISD002-P144-07 Study (PHASE2)
- Efficacy and Safety Study of p144 to Treat Skin Fibrosis in Systemic Sclerosis (PHASE2)
- Tolerability and Bioavailability of the P144 Peptide Inhibitor of TGF-β1 After Topical Administration in Healthy Volunteers (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |